module 13 DM Flashcards
Type 1
autoimmune destruction of Beta cells
type IV hypersensitivity
s/s do not arise until sufficient destruction has occurred, could be years after the initial trigger
type 2
insulin resistance
other types of diabetes
maturity onset diabetes of youth - genetic defect in insulin production or release Gestation DM - during preg Various endocrine disorders - cushings - acromegaly - pheochromocytoma
Type 1 clinical
onset < 20 normal weight dec. blood insulin anti-islet cell antibodies ketoacidosis is common
type 2 clinical
obese
inc. blood insulin
no antibodies
HHNK more common
Type 1 DM: 2 forms
1A: immune mediated - 3 subcategrories -- polygenic -- monogenic -- latent autoimmue 1B: idiopathic
polygenic 1A
2 or more genetic loci
monogenic 1A
rare assoc with IPEX syndrome
- immune dysfunction
- polyendocinopathy
- enteropathy
- X-linked
latent autoimmune 1A
development of T-cell reactivity in adulthood
Acute complications of DM
hypoglycemia: over tx
diabetic ketoacidosis
- no energy in cell, rely on fatty acid’s to work
Hyperosmolar hyperglycemic nonketotic syndrome (HHNKS)
ketogenesis
ketone bodies: used to generate energy without glucose
- acetoacetate
- acetone
- B-hydroxybutyrate
HHNK vs DKA
Glucose: HHNK(900) > DKA(600) Na: HHNK: high, DKA: nml pH: HHNK: slightly low, DKA: very low Bicarb: HHNK: slightly low, DKA: very low anion gap: DKA elevated
Risk factors DM type 2
aging
sedentary lifestyle
obesity
- inc. abd. fat inc. risk
chronic complications of DM
hyperglycemia and nonenzymatic glycosylation microvascular disease - retinopathy - nephropathy - cardiomyopathy Macrovascular disease - coronary artery disease - stroke - peripheral arterial disease - accelerated atherosclerosis diabetic neuropathy
glycosylation
glycosylation end products (AGE’s)
- proteins that bind to glucose
inc. glucose -> inc. binding -> inflammation